Jon Garramone - Manhattan, Kansas 66503

Jon Garramone is categorized under Doctors in Manhattan, KS .

Business Name: Jon Garramone
Contact Person: Jon Garramone
Address: 2709 Candlewood Drive, Manhattan, Kansas 66503
Phone Number: (785) 537-2184
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Chiara Joseph A MD - Manhattan, KS 66503
Klobasa C Louis MD - Manhattan, KS 66503
V L Bigbee Md - Manhattan, KS 66503
Wall Kevin K MD - Manhattan, KS 66503
Herl Cary MD - Manhattan, KS 66503
Mohmand Asad MD - Manhattan, KS 66503
Minocha Mikki MD - Manhattan, KS 66503
Mosier Steven J MD - Manhattan, KS 66503
Kiracofe Kent H MD - Manhattan, KS 66503
Chase Segen MD - Manhattan, KS 66503
Ditto Dane E MD - Manhattan, KS 66503
Wright Keith A MD - Manhattan, KS 66503
Short Steven MD - Manhattan, KS 66503
Singh Avinash MD - Manhattan, KS 66503
Mosier Michael L MD - Manhattan, KS 66503
Candlewood Medical Clinic - Manhattan, KS 66503
Dr Ronette Gehring - Manhattan, KS 66503
Mid-America Heart and Vascular Clinics, LLC - Manhattan, KS 66503
Way-Graves Karen DO - Manhattan, KS 66503
Stonecreek Family Physicians - Manhattan, KS 66503

The company Jon Garramone provides B2C services in the form of Doctors from its single location in Kansas. 1 to 4 employees work for Jon Garramone, and the business now earns $100.000 to $499.999 per annum.

Jon Garramone was launched in 2010 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Jon Garramone, please call Jon Garramone with the phone number (785) 537-2184 or visit its single location at 2709 Candlewood Drive in Manhattan, Kansas 66503.

The location of the single location can also be found using the coordinates 39.213167,-96.622049. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.